OCUL logo

Ocular Therapeutix (OCUL) Company Overview

Profile

Full Name:

Ocular Therapeutix, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 25, 2014

Indexes:

Not included

Description:

Ocular Therapeutix is a biotechnology company focused on developing innovative treatments for eye diseases. They create unique drug delivery systems to improve patient care and outcomes. Their products aim to address conditions like glaucoma and dry eye, enhancing the effectiveness of medications for better vision health.

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Mar 3, 2025

Recent annual earnings:

Mar 3, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 HC Wainwright & Co.
Buy
Mar 4, 25 Citizens Capital Markets
Market Outperform
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Oct 16, 24 Scotiabank
Sector Outperform
Oct 16, 24 HC Wainwright & Co.
Buy
Aug 8, 24 Baird
Outperform
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 21, 24 Piper Sandler
Overweight
Jun 20, 24 TD Cowen
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Ocular Therapeutix?
  • Does Ocular Therapeutix pay dividends?
  • What sector is Ocular Therapeutix in?
  • What industry is Ocular Therapeutix in?
  • What country is Ocular Therapeutix based in?
  • When did Ocular Therapeutix go public?
  • Is Ocular Therapeutix in the S&P 500?
  • Is Ocular Therapeutix in the NASDAQ 100?
  • Is Ocular Therapeutix in the Dow Jones?
  • When was Ocular Therapeutix's last earnings report?
  • When does Ocular Therapeutix report earnings?
  • Should I buy Ocular Therapeutix stock now?

What is the ticker symbol for Ocular Therapeutix?

The ticker symbol for Ocular Therapeutix is NASDAQ:OCUL

Does Ocular Therapeutix pay dividends?

No, Ocular Therapeutix does not pay dividends

What sector is Ocular Therapeutix in?

Ocular Therapeutix is in the Healthcare sector

What industry is Ocular Therapeutix in?

Ocular Therapeutix is in the Biotechnology industry

What country is Ocular Therapeutix based in?

Ocular Therapeutix is headquartered in United States

When did Ocular Therapeutix go public?

Ocular Therapeutix's initial public offering (IPO) was on July 25, 2014

Is Ocular Therapeutix in the S&P 500?

No, Ocular Therapeutix is not included in the S&P 500 index

Is Ocular Therapeutix in the NASDAQ 100?

No, Ocular Therapeutix is not included in the NASDAQ 100 index

Is Ocular Therapeutix in the Dow Jones?

No, Ocular Therapeutix is not included in the Dow Jones index

When was Ocular Therapeutix's last earnings report?

Ocular Therapeutix's most recent earnings report was on Mar 3, 2025

When does Ocular Therapeutix report earnings?

The next expected earnings date for Ocular Therapeutix is May 7, 2025

Should I buy Ocular Therapeutix stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions